AstraZeneca Vaccine Refusal
You will have seen the coverage in the media about some countries choosing to refuse the AstraZeneca vaccine due to concerns about clotting in some people – a comparatively small number compared to the number of vaccinations delivered.
The MHRA has today confirmed that the benefits of the vaccine in preventing COVID-19 far outweigh the risks. People should still go and get their COVID-19 vaccine when asked to do so.
The latest statement from the MHRA states:
Dr June Raine, MHRA Chief Executive, said:
“We continually monitor safety during use of all a vaccines to protect the public, and to ensure the benefits continue to outweigh the risks.
“Our thorough and careful review, alongside the critical assessment of leading, independent scientists, shows that there is no evidence that that blood clots in veins is occurring more than would be expected in the absence of vaccination, for either vaccine.
“We have received a very small number of reports of an extremely rare form of blood clot in the cerebral veins (sinus vein thrombosis, or CSVT) occurring together with lowered platelets soon after vaccination. This type of blood clot can occur naturally in people who have not been vaccinated, as well as in those suffering from COVID-19.
“Given the extremely rare rate of occurrence of these CSVT events among the 11 million people vaccinated, and as a link to the vaccine is unproven, the benefits of the vaccine in preventing COVID-19, with its associated risk of hospitalisation and death, continue to outweigh the risks of potential side effects.
“You should therefore continue to get your jab when it is your turn.
“While we continue to investigate these cases, as a precautionary measure we would advise anyone with a headache that lasts for more than 4 days after vaccination, or bruising beyond the site of vaccination after a few days, to seek medical attention.
“However, please remember that mild flu-like symptoms remain one of the most common side effects of any COVID-19 vaccine, including headache, chills and fever. These generally appear within a few hours and resolve within a day or two, but not everyone gets them.
“We will continue to robustly monitor all the data we have on this extremely rare possible side effect.” To read the full article, see: https://www.gov.uk/government/news/uk-regulator-confirms-that-people-should-continue-to-receive-the-covid-19-vaccine-astrazeneca
Our message to the public remains:
- The MHRA have undertaken robust testing and have confirmed that the vaccine is safe and offers high levels of protection against COVID-19
- Local clinicians are urging people to get their COVID-19 vaccine when they are invited without delay
- The MHRA are closely reviewing reports regarding the AstraZeneca vaccine and blood clotting but the evidence available does not suggest the vaccine is the cause
- More than 11 million doses of the COVID-19 Vaccine AstraZeneca have now been administered across the UK, and the number of blood clots reported after having the vaccine is not greater than the number that would have occurred naturally in the vaccinated population
The vaccine you will be given will be informed by whichever is available at your location and patients are not able to request a particular brand of vaccine based on their preference. |